## Core Concept
Brachytherapy is a form of cancer treatment where a sealed radiation source is placed inside or next to the area requiring treatment. The sources used in brachytherapy emit ionizing radiation, such as alpha, beta, or gamma rays, which help in killing cancer cells or slowing their growth. Various radioactive materials are utilized in brachytherapy, including isotopes of metals and elements.

## Why the Correct Answer is Right
Molybdenum-99 (Mo-99) is primarily used in nuclear medicine for the production of Technetium-99m (Tc-99m), a versatile radioactive tracer used in diagnostic imaging. Unlike the other options provided, which are directly used in brachytherapy for therapeutic purposes, Mo-99 is not directly implanted in or near tumors for treatment. Instead, it serves as a precursor for Tc-99m, which is then used for diagnostic imaging rather than therapy.

## Why Each Wrong Option is Incorrect
- **Option A:** Iridium-192 (Ir-192) is used in brachytherapy, particularly for treating certain types of cancer and in industrial applications. It is a high-dose-rate brachytherapy source.
- **Option B:** Cesium-137 (Cs-137) has been used in brachytherapy for treating various cancers. It emits gamma radiation and has been utilized in both low-dose-rate and high-dose-rate applications.
- **Option D:** Cobalt-60 (Co-60) is another radioactive isotope used in brachytherapy, especially for treating cancer. It emits gamma rays and has been used in both brachytherapy and external beam radiation therapy.

## Clinical Pearl / High-Yield Fact
A key point to remember is that while many radioactive isotopes are used in medicine, their applications are highly specific. Mo-99/Tc-99m is primarily for **diagnostic** purposes, not therapy. This distinction is crucial for understanding the role of different isotopes in patient care and for ensuring the correct application of radioactive materials in medical treatment.

## Correct Answer: .